Herbalife (NYSE:HLF) Price Target Lowered to $12.00 at B. Riley

Herbalife (NYSE:HLFGet Free Report) had its target price dropped by stock analysts at B. Riley from $17.00 to $12.00 in a note issued to investors on Thursday, Benzinga reports. The firm presently has a “buy” rating on the stock. B. Riley’s price objective points to a potential upside of 52.67% from the stock’s current price. B. Riley also issued estimates for Herbalife’s FY2025 earnings at $1.83 EPS.

A number of other research firms have also weighed in on HLF. Citigroup lowered their price objective on shares of Herbalife from $16.00 to $13.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. DA Davidson lifted their price objective on shares of Herbalife from $9.50 to $13.00 and gave the company a “neutral” rating in a research report on Thursday, August 1st. Finally, StockNews.com downgraded Herbalife from a “buy” rating to a “hold” rating in a report on Tuesday, October 22nd. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $10.42.

View Our Latest Research Report on Herbalife

Herbalife Trading Up 4.1 %

Shares of HLF opened at $7.86 on Thursday. The firm has a market cap of $791.66 million, a PE ratio of 9.25, a price-to-earnings-growth ratio of 0.26 and a beta of 1.19. The company’s 50 day simple moving average is $7.33 and its 200-day simple moving average is $9.29. Herbalife has a 12-month low of $6.59 and a 12-month high of $15.66.

Herbalife (NYSE:HLFGet Free Report) last announced its earnings results on Wednesday, October 30th. The company reported $0.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.19 by $0.38. Herbalife had a net margin of 1.73% and a negative return on equity of 18.25%. The business had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.23 billion. As a group, equities research analysts forecast that Herbalife will post 1.34 EPS for the current fiscal year.

Insider Transactions at Herbalife

In other news, Director Juan Miguel Mendoza purchased 10,000 shares of the business’s stock in a transaction dated Monday, September 9th. The stock was acquired at an average price of $7.11 per share, with a total value of $71,100.00. Following the purchase, the director now directly owns 120,000 shares of the company’s stock, valued at $853,200. This represents a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.94% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Russell Investments Group Ltd. raised its stake in shares of Herbalife by 5,249.2% during the 1st quarter. Russell Investments Group Ltd. now owns 138,599 shares of the company’s stock worth $1,390,000 after buying an additional 136,008 shares during the last quarter. Capstone Investment Advisors LLC purchased a new stake in Herbalife during the 1st quarter worth about $1,397,000. Price T Rowe Associates Inc. MD increased its position in Herbalife by 4.6% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 82,287 shares of the company’s stock worth $827,000 after purchasing an additional 3,647 shares in the last quarter. Baupost Group LLC MA increased its position in Herbalife by 128.3% during the 2nd quarter. Baupost Group LLC MA now owns 5,124,526 shares of the company’s stock worth $53,244,000 after purchasing an additional 2,879,603 shares in the last quarter. Finally, Maverick Capital Ltd. increased its position in Herbalife by 409.4% during the 2nd quarter. Maverick Capital Ltd. now owns 127,887 shares of the company’s stock worth $1,329,000 after purchasing an additional 102,784 shares in the last quarter.

Herbalife Company Profile

(Get Free Report)

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.

Further Reading

Analyst Recommendations for Herbalife (NYSE:HLF)

Receive News & Ratings for Herbalife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife and related companies with MarketBeat.com's FREE daily email newsletter.